vimarsana.com
Home
Live Updates
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript : vimarsana.com
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call.
Related Keywords
Delaware ,
United States ,
New Jersey ,
Mihael Polymeropoulos ,
Mihaelh Polymeropoulos ,
Tim Williams ,
Andrew Tsai ,
Kevin Moran ,
Nasdaq ,
Circuit Court ,
Vanda Pharmaceuticals Inc ,
Vanda Pharmaceuticals ,
Call Transcript July ,
Chief Financial ,
Vanda Pharmaceutical ,
Chief Executive Officer ,
Risk Factors ,
Financial Condition ,
General Counsel ,
Orphan Drug Designation ,
Antisense Oligonucleotide ,
Federal Circuit ,
Federal Circuit Court ,
Lanham Act ,
Federal Claims ,
vimarsana.com © 2020. All Rights Reserved.